JP2023509214A5 - - Google Patents
Info
- Publication number
- JP2023509214A5 JP2023509214A5 JP2022542268A JP2022542268A JP2023509214A5 JP 2023509214 A5 JP2023509214 A5 JP 2023509214A5 JP 2022542268 A JP2022542268 A JP 2022542268A JP 2022542268 A JP2022542268 A JP 2022542268A JP 2023509214 A5 JP2023509214 A5 JP 2023509214A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence shown
- chain variable
- heavy chain
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/071340 | 2020-01-10 | ||
| CN2020071340 | 2020-01-10 | ||
| PCT/CN2021/070899 WO2021139776A1 (en) | 2020-01-10 | 2021-01-08 | Anti-tigit antibodies, multispecific antibodies comprising the same and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509214A JP2023509214A (ja) | 2023-03-07 |
| JP2023509214A5 true JP2023509214A5 (cg-RX-API-DMAC7.html) | 2024-01-16 |
| JP7840852B2 JP7840852B2 (ja) | 2026-04-06 |
Family
ID=76787748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542268A Active JP7840852B2 (ja) | 2020-01-10 | 2021-01-08 | 抗tigit抗体、それを含む多重特異性抗体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12415858B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4087862A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7840852B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220131260A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115066431B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021205565B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022013298A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3164283A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021139776A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202208798B (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110818795B (zh) * | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
| TW202216778A (zh) | 2020-07-15 | 2022-05-01 | 美商安進公司 | Tigit及cd112r阻斷 |
| WO2022268168A1 (zh) * | 2021-06-23 | 2022-12-29 | 迈威(上海)生物科技股份有限公司 | 靶向lag-3和pd-l1的新型双特异抗体及其应用 |
| CN120590537A (zh) * | 2021-12-31 | 2025-09-05 | 南京维立志博生物科技股份有限公司 | 靶向tigit的双特异性抗体 |
| TW202417512A (zh) * | 2022-10-17 | 2024-05-01 | 英屬開曼群島商百濟神州有限公司 | 含有抗tigit抗體的配製物及其使用方法 |
| WO2025170315A1 (ko) * | 2024-02-05 | 2025-08-14 | 주식회사 트리오어 | 이중 기능 도메인을 포함하는 융합단백질 및 이의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR103268A1 (es) * | 2014-12-23 | 2017-04-26 | Bristol Myers Squibb Co | Anticuerpos contra tigit |
| TWI715587B (zh) * | 2015-05-28 | 2021-01-11 | 美商安可美德藥物股份有限公司 | Tigit結合劑和彼之用途 |
| SG10202007764TA (en) | 2015-09-25 | 2020-09-29 | Genentech Inc | Anti-tigit antibodies and methods of use |
| US10544222B2 (en) * | 2015-11-18 | 2020-01-28 | Merck Sharp & Dohme Corp. | PD1/CTLA4 binders |
| KR102379464B1 (ko) * | 2016-06-20 | 2022-03-29 | 키맵 리미티드 | 항-pd-l1 항체 |
| EP3565839A4 (en) * | 2017-01-05 | 2021-04-21 | Gensun Biopharma Inc. | CHECKPOINT REGULATOR ANTAGONISTS |
| US11673954B2 (en) | 2017-11-17 | 2023-06-13 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against PD-L1 |
| CN109966487B (zh) * | 2017-12-28 | 2023-08-25 | 上海复宏汉霖生物制药有限公司 | 一种包含抗pd-l1单克隆抗体的药物配制剂 |
| SG11202004521QA (en) * | 2018-02-06 | 2020-06-29 | I Mab Biopharma Us Ltd | Antibodies to t cell immunoreceptor with ig and itim domains (tigit) and uses thereof |
| CN110818795B (zh) * | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
-
2021
- 2021-01-08 WO PCT/CN2021/070899 patent/WO2021139776A1/en not_active Ceased
- 2021-01-08 JP JP2022542268A patent/JP7840852B2/ja active Active
- 2021-01-08 BR BR112022013298A patent/BR112022013298A2/pt unknown
- 2021-01-08 AU AU2021205565A patent/AU2021205565B2/en active Active
- 2021-01-08 KR KR1020227027448A patent/KR20220131260A/ko active Pending
- 2021-01-08 EP EP21738025.2A patent/EP4087862A4/en active Pending
- 2021-01-08 CA CA3164283A patent/CA3164283A1/en active Pending
- 2021-01-08 CN CN202180008450.3A patent/CN115066431B/zh active Active
-
2022
- 2022-07-08 US US17/811,541 patent/US12415858B2/en active Active
- 2022-08-05 ZA ZA2022/08798A patent/ZA202208798B/en unknown